Therapy for Tuberculosis: M. Vaccae Inclusion Into Routine Treatment

doi 10.5772/31811
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Mycobactin and the Competition for Iron Between Mycobacterium Neoaurum and M. Vaccae

Microbiology
Microbiology
1986English

Are Routine Tuberculosis Programme Data Suitable to Report on Antiretroviral Therapy Use of HIV-infected Tuberculosis Patients?

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2013English

Treatment for Inclusion Body Myositis

2014English

When to Start Antiretroviral Therapy During Tuberculosis Treatment?

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2013English

Incorporation of Pyrazinamide Into Community-Wide Treatment of Tuberculosis.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1990English

Directly Observed Therapy and Treatment Completion for Tuberculosis in the United States: Is Universal Supervised Therapy Necessary?

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1998English

Effect of Routine Isoniazid Preventive Therapy on Tuberculosis Incidence Among HIV-Infected Men in South Africa

JAMA - Journal of the American Medical Association
Medicine
2005English

Directly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand

PLoS ONE
Multidisciplinary
2008English

Treatment Outcomes After Early Initiation of Antiretroviral Therapy for Human Immunodeficiency Virus–associated Tuberculosis

Hong Kong Medical Journal
Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy